International Study of Biofield Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03994809|
Recruitment Status : Completed
First Posted : June 21, 2019
Last Update Posted : June 21, 2019
|Condition or disease||Intervention/treatment|
|Pain Depression, Anxiety Dizziness Signs and Symptoms||Other: Okada Purifying Therapy|
|Study Type :||Observational|
|Actual Enrollment :||12000 participants|
|Official Title:||International Cross-sectional Study on the Effectiveness of Biofield Therapy for the Relief of Various Symptoms|
|Actual Study Start Date :||January 1, 2008|
|Actual Primary Completion Date :||September 30, 2010|
|Actual Study Completion Date :||September 30, 2010|
- Other: Okada Purifying Therapy
The practitioner raises his/her hand forward towards the recipient with the palm directed toward the recipient. The practitioner uses his/her hands alternately during the administration of Okada Purifying Therapy. The distance between the palm and the body is usually 1-2 feet, with each session typically lasting 30 to 60 minutes.
- improvement/exacerbation rate of symptoms after a single session of biofield therapy [ Time Frame: Up to one year after all the data were collected. ]The Mann-Whitney test was conducted to compare the improvement/exacerbation rates between countries.
- adjusted odds ratio of the factors associated with the changes in symptoms [ Time Frame: Up to one year after all the data were collected. ]Logistic regression analyses
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03994809
|Study Chair:||Kiyoshi Suzuki, MD, PhD||MOA Health Science Foundation|